CN117165494A - Kiwi fruit canker biocontrol strain Wq-1 and application thereof - Google Patents
Kiwi fruit canker biocontrol strain Wq-1 and application thereof Download PDFInfo
- Publication number
- CN117165494A CN117165494A CN202311351701.5A CN202311351701A CN117165494A CN 117165494 A CN117165494 A CN 117165494A CN 202311351701 A CN202311351701 A CN 202311351701A CN 117165494 A CN117165494 A CN 117165494A
- Authority
- CN
- China
- Prior art keywords
- kiwi
- canker
- kiwi fruit
- strain
- liquid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000298697 Actinidia deliciosa Species 0.000 title claims abstract description 93
- 235000009436 Actinidia deliciosa Nutrition 0.000 title claims abstract description 88
- 230000000443 biocontrol Effects 0.000 title claims abstract description 13
- 239000007788 liquid Substances 0.000 claims abstract description 24
- 230000001580 bacterial effect Effects 0.000 claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 18
- 230000004151 fermentation Effects 0.000 claims abstract description 18
- 235000009434 Actinidia chinensis Nutrition 0.000 claims abstract description 17
- 241000589615 Pseudomonas syringae Species 0.000 claims abstract description 15
- 238000000034 method Methods 0.000 claims abstract description 9
- 238000004321 preservation Methods 0.000 claims abstract description 9
- 230000003405 preventing effect Effects 0.000 claims abstract description 7
- 239000012880 LB liquid culture medium Substances 0.000 claims abstract description 6
- 238000009629 microbiological culture Methods 0.000 claims abstract description 4
- 244000005700 microbiome Species 0.000 claims abstract description 4
- 230000001717 pathogenic effect Effects 0.000 claims description 12
- 230000003042 antagnostic effect Effects 0.000 claims description 10
- 238000010790 dilution Methods 0.000 claims description 8
- 239000012895 dilution Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 6
- 241000555281 Brevibacillus Species 0.000 claims description 2
- 238000011282 treatment Methods 0.000 abstract description 15
- 238000012258 culturing Methods 0.000 abstract description 12
- 244000052616 bacterial pathogen Species 0.000 abstract description 11
- 241000894006 Bacteria Species 0.000 abstract description 7
- 241000193417 Brevibacillus laterosporus Species 0.000 abstract description 7
- 239000003085 diluting agent Substances 0.000 abstract description 6
- 230000002265 prevention Effects 0.000 abstract description 5
- 238000005507 spraying Methods 0.000 abstract description 4
- 230000000813 microbial effect Effects 0.000 abstract description 2
- 230000008485 antagonism Effects 0.000 abstract 1
- 238000007670 refining Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 9
- 239000001963 growth medium Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 241000196324 Embryophyta Species 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 238000005070 sampling Methods 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000005764 inhibitory process Effects 0.000 description 3
- 239000002420 orchard Substances 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 229960005322 streptomycin Drugs 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 108020004465 16S ribosomal RNA Proteins 0.000 description 2
- 244000298715 Actinidia chinensis Species 0.000 description 2
- 241001052560 Thallis Species 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 241001576300 endophytic bacterium Species 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000011392 neighbor-joining method Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 241000219068 Actinidia Species 0.000 description 1
- 241000219066 Actinidiaceae Species 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 239000010751 BS 2869 Class A2 Substances 0.000 description 1
- 241000723920 Bacillus subtilis B2 Species 0.000 description 1
- 238000007400 DNA extraction Methods 0.000 description 1
- 240000006509 Gynostemma pentaphyllum Species 0.000 description 1
- 235000002956 Gynostemma pentaphyllum Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 241001631271 Prunus fasciculata Species 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000035613 defoliation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000012982 microporous membrane Substances 0.000 description 1
- 239000002366 mineral element Substances 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 238000012257 pre-denaturation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
The invention discloses a kiwi canker biocontrol strain Wq-1 and application thereof, belonging to Brevibacillus laterosporus,Preservation number: CGMCC No.27264, date of preservation: 2023, 5, 4, deposit unit: china general microbiological culture Collection center, preservation address: the institute of microorganisms of national academy of sciences of China, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing. The method for preventing and treating kiwi fruit canker by using the strain Wq-1 comprises the following steps: inoculating the strain Wq-1 into an LB liquid culture medium for culturing, obtaining fermentation seed liquid, then performing expansion culture, and finally preparing a fermentation culture liquid into a diluent liquid for spraying on kiwi fruit plants. The strain is endophytic bacteria separated from collected healthy kiwi fruit plants, and is used for refining kiwi fruitsThe pathogenic bacteria of the bacterial canker, pseudomonas syringae and kiwi fruits have strong antagonism, can obviously inhibit the growth of the pathogenic bacteria, can effectively prevent and treat the canker of the kiwi fruits, and provide a new microbial germplasm resource for the biological prevention and treatment of the canker of the kiwi fruits.
Description
Technical Field
The invention belongs to the technical field of biological control of plant protection, and particularly relates to a bacterial Brevibacillus laterosporus Wq-1 for preventing and controlling kiwi fruit canker by using a bacterial strain Wq-1.
Background
Kiwi fruitActinidiaLindl) is a perennial vine belonging to the genus actinidia of the family actinidiaceae, known separately as wild peach, sheep peach, kiwifruit (Kiwifruit). The fruits contain rich dietary fibers, vitamins, mineral elements, amino acids and bioactive substances, especially the Vc content is high (90-420 mg in 100 g fresh pulp), and the fruit is a reputation of 'king' of fruits; the kiwi fruit can be eaten fresh, can be processed into jam, fruit juice and the like, has important medical care value, and has wide market prospect.
In recent years, the kiwi fruit industry has been rapidly developed in more than 30 countries worldwide, the total cultivation area is about 20 ten thousand hectares, the yield is up to 240 ten thousand tons, wherein the cultivation area and yield of Chinese kiwi fruit are the largest, respectively account for 53% and 38% of the world share, in Italy, and in New Zealand, the third. Along with the annual increase of the planting area and the gradual expansion of the production scale of the kiwi fruits, the problem of kiwi fruit diseases is also increasingly highlighted. Of these, the most typical is bacterial canker of kiwifruit, which is a disease produced by a pathogenic variant of Pseudomonas syringae kiwifruitPseudomonas syringae pv. actinidiae) The main trunk, branches, tendrils, leaves and the like of the kiwi fruit are mainly damaged, and the kiwi fruit has the characteristics of rapid transmission, strong pathogenicity, high control difficulty and the like, and is extremely easy to cause large-area death of the tree body in a short period. The disease was first discovered in japan in 1984, and has occurred in countries such as the united states, japan, italy, new zealand, korea, and chile, and areas such as the shanxi, chongqing, sichuan, and Hunan of china, causing great economic loss to the world kiwi fruit industry. For example, the export loss of the kiwi fruit canker in New Zealand 2010-2014 is reduced by 9300 hundred million New Zealand, and the kiwi fruit canker loss in China is accumulated to 3.23 hundred million yuan in 2013 only. Chinese, new Zealand, U.S. and European plant protection groups (EPPO) have classified kiwifruit canker as a plant quarantine subject and a class A2 quarantine pest, respectively, to control the rapid spread of the disease.
At present, the measures for controlling the kiwi canker mainly comprise excellent resistant variety breeding, chemical control and biological control besides scientific and standard agricultural management, wherein the biological control has the characteristics of environmental friendliness, human and animal safety, sustainability, strong specificity for pathogenic bacteria and the like, meets the requirements of people on green foods and is favored by a plurality of scholars. Shao Baolin et al (2015) obtain bacillus subtilis B2 from kiwi fruit rhizosphere soil, and both pot culture and field experiments show a certain effect of preventing and treating canker; cui Ligong et al (2017) obtain bacteria (JDG 6, JDG16, JDG 23) from gynostemma pentaphylla rhizosphere soil, which can obviously reduce the occurrence of kiwi fruit canker; kim et al (2019) are separated into 3 actinomycetes from rhizosphere and leaf circumference of kiwi fruits, and have remarkable control effect on canker of kiwi fruits; wicaksono et al (2018) isolated from the medicinal plant M ā nuka to 3 endophytes inhibiting the canker Psa, can reduce the occurrence of canker in the Chinese goosebeery and the like to a certain extent. Although some achievements are achieved in the study on the biological control of kiwi fruit canker, serious disadvantages still exist: at present, most biocontrol strains are derived from soil, kiwi fruit rhizosphere and leaf circumference, and are extremely easily influenced by environmental factors (climate, temperature and humidity, soil property and the like) in the application process, so that the biocontrol effect is unstable and not ideal. Since the endophyte has specificity to the choice of host plant, and is not easy to be interfered by external environment factors. Therefore, the research and development of the kiwi fruit indigenous endophytic bacteria as the canker biocontrol strain thereof has wide application prospect.
Disclosure of Invention
The invention aims to overcome the defects of the prior art and provide a kiwi fruit indigenous endophytic bacterium which is an antagonistic strain of a pseudomonas syringae kiwi fruit pathogenic variety which is a kiwi fruit canker pathogenic bacterium, and the kiwi fruit canker can be effectively prevented and treated by using the strain; meanwhile, the invention also provides a method for biologically preventing and treating kiwi fruit canker by using the strain.
The inventor collects healthy branches and leaves of Miliang No. 1 and red sun kiwi fruits at a kiwi fruit plantation sampling point in Hunan Xiang West area, puts the branches and leaves into an ice box and returns the ice box to a laboratory, and separates and screens 1 endophytic bacterial strain inhibiting the growth of kiwi fruit canker pathogenic bacteria, namely pseudomonas syringae kiwi fruit pathogenic varieties from the sampleThe antagonistic strain of (2) is identified and named as Brevibacillus laterosporus Wq-1%Brevibacillus laterosporusWq-1), and deposited with deposit number: CGMCC No.27264, date of preservation: 2023, 5, 4, deposit unit: china general microbiological culture Collection center, preservation address: the institute of microorganisms of national academy of sciences of China, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing.
The isolation and screening steps of the strain Wq-1 comprise:
(1) Taking an orchard with frequent kiwi fruit canker in the western Hunan area of Hunan as a sampling point, collecting branches and leaves of healthy Miliang No. 1 and red sun kiwi fruit plants, and putting the branches and leaves into an ice box for later use. Surface sterilizing the branch and leaf sample, shearing to proper size, adding into sterilized grinding bowl, adding 5-10 mL sterile water, and grinding. Standing for 5-10 min, sucking upper liquid, and sequentially performing 10 -1 Multiple of 10 -2 Multiple of 10 -3 Dilution with multiple gradients; dilutions of 0.1. 0.1 mL were applied to LB medium solid plates, each dilution was repeated 3 times, and the culture was inverted at 28 ℃.
(2) Single colony grows on the plate to be coated, colonies with different forms are picked, and the colonies are respectively inoculated on LB solid culture medium for culture by adopting a four-area streak method; repeating the purification for 3 generations, transferring the culture to an LB solid culture medium inclined surface test tube for culture, and then preserving at 4 ℃.
(3) Inoculating the pathogenic bacteria of the kiwi canker of the pseudomonas syringae and the kiwi fruits to an LB liquid culture medium for culturing 24 h, and sucking the bacterial liquid and coating the bacterial liquid on an LB solid culture medium plate for later use. And (3) selecting single colony points of the separated endophytic bacteria on the plates, inoculating 3-4 sites on each plate, culturing at the constant temperature of 28 ℃, observing the antibacterial condition, and generating a antibacterial zone, namely the antagonistic strain of the pseudomonas syringae kiwi fruit pathogenic variety.
(4) Fermenting and culturing the primary screened antagonistic strain, centrifuging, absorbing 200 mL fermentation liquor, transferring into oxford cup coated with pseudomonas syringae kiwi fruit pathogenic variant plate, observing the size of bacteriostasis zone around oxford cup, and screening strain with strong antagonistic effect. The species were identified based on morphology and 16S rRNA gene sequence analysis.
The endophytic bacteria with excellent effect of antagonizing the pseudomonas syringae and the kiwi fruit pathogenic varieties is the biocontrol strain of the kiwi fruit canker, can be used for biological control of the kiwi fruit canker, and comprises the following steps:
(1) Inoculating antagonistic strains of the pseudomonas syringae kiwi fruit pathogenic varieties into an LB liquid culture medium for culture to obtain fermentation seed liquid;
(2) Inoculating the fermentation seed liquid to an LB liquid culture medium for expansion culture to obtain a fermentation culture liquid.
(3) Preparing a fermentation culture solution into a dilution solution with a certain concentration (comprising thalli, and the bacterial concentration is more than or equal to 1 multiplied by 10) 3 cfu/mL, namely the total number of bacterial colonies per milliliter is more than or equal to 1000), aiming at the spraying of kiwi fruit plants, the effective control of kiwi fruit canker can be realized.
Compared with the prior art, the invention has the beneficial effects that:
the invention provides a novel kiwi canker biocontrol strain Wq-1, which is an indigenous endophyte strain of kiwi, namely an antagonistic strain of a pathogenic variety of kiwi of pathogenic bacteria, namely pseudomonas syringae, of kiwi canker, and is identified and named as Brevibacillus laterosporus Wq-1%Brevibacillus laterosporus Wq-1)。
The strain is endophytic bacteria obtained by separating and purifying branches of the acquired kiwi fruit plants, has a strong inhibition effect on the pathogenic bacteria of the kiwi fruit bacterial canker, namely pseudomonas syringae and kiwi fruit, can obviously inhibit the growth and propagation of the pathogenic bacteria of the kiwi fruit bacterial canker, can effectively prevent and treat the kiwi fruit canker, and provides a new microbial germplasm resource for the biological prevention and treatment of the kiwi fruit canker.
The strain is a kiwi endophytic bacterium, can mutually and symbiotically with plant tissues, has small interference by external environmental factors, stable performance, convenient spraying and remarkable kiwi ulcer prevention and treatment effect, provides an environment-friendly, simple and effective method for kiwi ulcer prevention and treatment, and is beneficial to environmental protection and organic kiwi production.
Detailed Description
The method for preventing and treating the kiwi fruit canker by using the kiwi fruit canker biocontrol strain Wq-1 and the application strain Wq-1 is further specifically described by combining the specific embodiments.
And 2021, taking a kiwi fruit plantation in the Hunan Xiangxi area as a sampling point, collecting samples of branches and leaves of unaffected 'Miliang No. 1' and 'hongyang' kiwi fruits, taking the samples of the kiwi fruit plantation as sampling points, taking the samples of the kiwi fruit plantation with the longitude and latitude of N26 degrees of 36'30E114 degrees of 07'33, and taking the samples of the branches and leaves of the unaffected 'Miliang No. 1' and 'hongyang' kiwi fruits back to a laboratory for standby in an ice box. Sequentially soaking with 75% ethanol for 1 min, 1% sodium hypochlorite for 5 min, and 75% ethanol for 1 min, respectively sterilizing the surfaces of the branches and leaves, shearing to proper size, placing into sterilized grinding bowl, adding 5-10 mL sterile water, and grinding. Standing for 5-10 min, sucking upper liquid, and sequentially performing 10 -1 Multiple of 10 -2 Multiple of 10 -3 And (5) performing multiple gradient dilution. Respectively coating 0.1-mL gradient dilutions on LB culture medium plates, repeating each dilution for 3 times, inversely culturing in a constant temperature incubator at 28 ℃ for 1-2 d, and growing single colony on the plates to be coated; selecting colonies with different forms, and respectively inoculating the colonies on an LB solid medium for culture by adopting a four-area streak method; repeatedly purifying for 3 generations, transferring LB solid culture medium, performing slant culture, and storing in a refrigerator at 4deg.C.
Culturing pathogenic bacteria of kiwi canker, pseudomonas syringae and kiwi fruit pathogenic variety overnight, taking 50 mu L of bacterial liquid, and coating on LB culture medium for standby. And (3) selecting single colony points of the separated endophytic bacteria on the plates, inoculating 3-4 sites on each plate, culturing at the constant temperature of 28 ℃, observing the antibacterial condition after 2-3 d, and generating an antibacterial zone, namely the antagonistic strain of the pseudomonas syringae kiwi fruit pathogenic variety.
Inoculating the strain with strong antibacterial activity into 5 mL LB liquid medium, shake culturing at 28deg.C and 180 r/min for 24 h to obtain seed liquid, then taking 100 μL, inoculating into 50 mL LB liquid medium, culturing at 28deg.C and 180 r/min for 48 h, transferring the fermentation liquid into sterile centrifuge tube, centrifuging at 4deg.C and 10000 r/min for 10 min, centrifuging, and filtering with 0.22 μm microporous membrane to obtain supernatant. Meanwhile, the pathogenic bacteria pseudomonas syringae and kiwi fruit pathogenic varieties are cultured overnight, and 50 mu L of bacterial liquid is coated on an LB culture medium for standby.
Placing oxford cup on a plate coated with pathogenic bacteria, transferring 200 μl of supernatant into oxford cup, repeating each strain for 3 times, culturing at 28deg.C at constant temperature, and observing antibacterial condition after 2-3 d to obtain a good strain with antibacterial circle diameter up to 2 times of colony diameter ratio.
After the strain is cultured in an LB culture medium for 24 h, a colony is milky white, colloidal, smooth and moist in surface, convex in center, neat in edge and normal in viscosity. Extracting and separating total DNA of the bacterial strain by using a bacterial genome DNA extraction kit, and carrying out PCR amplification on 16S rRNA gene segments of the separated bacterial strain by using a bacterial universal primer PA/PB (PA: 5'-AGAGTTTGATCCTGGCTCA G-3'; PB: 5'-TTAAGGTGATCCA GCCGCA-3'), wherein the reaction system is as follows: taq PCR Mix (2×) 25 μl; 1 mu L of each forward primer and reverse primer; 2 mu L of template; sterile water was filled to 50 μl. The PCR procedure was: pre-denaturation at 95℃for 2.5 min; denaturation at 95℃for 15 s, annealing at 55℃for 30 s, elongation at 72℃for 1 min,30 cycles; extending for 10 min at 72 ℃. The PCR amplified products were subjected to agarose gel electrophoresis and then sent to the biological engineering (Shanghai) Co., ltd for sequencing. Submitting the detected sequence to GenBank (http:// www.ncbi.nlm.nih.gov) database, searching homologous sequences by Blast tool software, comparing, constructing a phylogenetic tree by using the neighbor joining method (NJ) of Mega7.0 software, and identifying and naming the strain as Brevibacillus laterosporus Wq-1 according to phylogenetic relation analysisBrevibacillus laterosporusWq-1), and deposited with deposit number: CGMCC No.27264, date of preservation: 2023, 5, 4, deposit unit: china general microbiological culture Collection center, preservation address: the institute of microorganisms of national academy of sciences of China, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing.
The biocontrol strain for kiwi fruit canker is used for biological control of kiwi fruit canker, and comprises the following specific implementation steps:
inoculating the strain Wq-1 into 100 mL LB liquid medium, and carrying out shaking culture at 28 ℃ and 180 r/min for 24 h to obtain fermentation seed liquid; inoculating the fermentation seed liquid into 1L LB liquid medium at 1% inoculum size, shake culturing at 28deg.C and 180 r/min, and culturing whenOD 600 And harvesting the fermentation culture solution when the fermentation culture solution reaches 1.2.
The fermentation culture solution is prepared into a diluent with a certain concentration (containing thalli, the bacterial concentration is 1080 cfu/mL, namely, the total bacterial colony number per milliliter is 1080), and the diluent is used as a treatment group 1, a 72% agricultural streptomycin 600-time diluent is used as a treatment group 2, and sterile clear water is used as a control group (treatment group 3). And (3) field efficacy test: selecting 3 red-sun kiwi fruit gardens with 3 ages of 3-5 a, randomly dividing 3 cells in each orchard for 3 treatments, wherein 50 kiwi fruits are treated in each treatment, namely 3 repetition in 3 orchards, and investigating 150 kiwi fruits in each group. And in the key period from fruit picking in autumn to defoliation, spraying the whole kiwi fruit plant with each corresponding medicament for 3 times at intervals of 10 d. And counting the percentage of the trunk, yellow brown or rust red ulcer disease plants in each treatment group in the high-incidence period (2-3 months) of the kiwi ulcers in the spring, taking the percentage as the disease rate of the ulcer disease rate, and calculating the field disease prevention effects of different treatments according to the following formula.
Disease preventing effect= (control morbidity-treatment morbidity)/control morbidity x 100%
Through statistics, the average inhibition rate of the field efficacy test of the strain Wq-1 group (treatment group 1) reaches 92.5%, and the average inhibition rate of the field efficacy test of the 72% agricultural streptomycin 600-time diluent group (treatment group 2) reaches 65.6%. Further field control experiments prove that: the strain Wq-1 fermentation broth was further diluted 10-fold (1X 10) 2 cfu/mL) still has a stronger kiwi canker prevention and treatment effect, can reach 84.5%, and is superior to a 600-time diluent of 72% agricultural streptomycin. Therefore, the Brevibacillus laterosporus Wq-1 has ideal control effect on kiwi fruit canker, and is an excellent kiwi fruit canker biocontrol strain.
Claims (2)
1. A biocontrol strain Wq-1 for kiwi canker belongs to Brevibacillus laterosporusBrevibacillus laterosporus) Antagonistic strains of pseudomonas syringae and kiwi fruit pathogenic varieties are stored with the number: CGMCC No.27264, date of preservation: 2023, 5, 4, deposit unit: china general microbiological culture Collection center, preservation address: the institute of microorganisms of national academy of sciences of China, no. 1, no. 3, north Chen West Lu, the Korean region of Beijing.
2. A method for preventing and controlling kiwi fruit canker by using kiwi fruit canker biocontrol strain Wq-1 is characterized by comprising the following steps:
(1) Inoculating the strain Wq-1 into an LB liquid culture medium for culture to obtain fermentation seed liquid;
(2) Inoculating the fermentation seed liquid into an LB liquid culture medium for expansion culture to obtain a fermentation culture liquid;
(3) Preparing a certain concentration dilution liquid (bacterial concentration is more than or equal to 1 multiplied by 10) from the fermentation culture solution 3 cfu/mL), aiming at kiwi fruit plants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311351701.5A CN117165494A (en) | 2023-10-18 | 2023-10-18 | Kiwi fruit canker biocontrol strain Wq-1 and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311351701.5A CN117165494A (en) | 2023-10-18 | 2023-10-18 | Kiwi fruit canker biocontrol strain Wq-1 and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117165494A true CN117165494A (en) | 2023-12-05 |
Family
ID=88939675
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311351701.5A Pending CN117165494A (en) | 2023-10-18 | 2023-10-18 | Kiwi fruit canker biocontrol strain Wq-1 and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117165494A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115873744A (en) * | 2022-07-27 | 2023-03-31 | 贵州大学 | Kiwi fruit endogenous antagonistic bacterium Bacillus beleisi and application thereof |
-
2023
- 2023-10-18 CN CN202311351701.5A patent/CN117165494A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115873744A (en) * | 2022-07-27 | 2023-03-31 | 贵州大学 | Kiwi fruit endogenous antagonistic bacterium Bacillus beleisi and application thereof |
CN115873744B (en) * | 2022-07-27 | 2024-03-19 | 贵州大学 | Kiwi endophytic antagonistic bacterium bacillus belicus and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112175888B (en) | Bacillus belgii Hsg1949 and application thereof | |
CN108148794B (en) | Bacillus subtilis DYr3.3 with broad-spectrum antibacterial activity, and preparation method and application thereof | |
KR101624628B1 (en) | Novel bacillus vallismortis bs07m with promoting effect of plant growth and improving effect of cold-tolerance, and microbial agent containing the same | |
CN108148793B (en) | Paenibacillus polymyxa DYr4.4 with broad-spectrum antibacterial activity and preparation method and application thereof | |
CN111040976B (en) | Bacillus amyloliquefaciens and application thereof | |
CN112795496A (en) | Paenibacillus polymyxa and application thereof in preventing and treating stem basal rot of Chinese cabbage | |
CN117165494A (en) | Kiwi fruit canker biocontrol strain Wq-1 and application thereof | |
CN109749953B (en) | Bacillus cereus, microbial inoculum and preparation method and application thereof | |
CN114806896A (en) | Alternaria alternata, herbicide and application thereof | |
CN113151044B (en) | Pseudomonas for preventing and treating diseases of radix pseudostellariae and separation, screening and identification method and application | |
CN110317747A (en) | A kind of bacillus amyloliquefaciens JT68 and its application in prevention and treatment tea anthracnose | |
CN109112069B (en) | Biocontrol endophytic fungus and application thereof | |
CN115960777B (en) | Bacillus pseudomycoides and application thereof in prevention and treatment of vegetable epidemic disease | |
CN108441443B (en) | Strain for preventing and treating plant nematodes and application thereof | |
CN108102992B (en) | Microbacterium aurantiacus and application thereof in prevention and treatment of tomato root-knot nematodes | |
CN114032182B (en) | Fungus with functions of antagonizing pathogenic bacteria of garlic root rot and promoting growth | |
CN114085788B (en) | Pseudomonas amazonensis strain and application thereof | |
CN112322561B (en) | Klebsiella and application thereof in prevention and treatment of pear fire blight of fruit trees | |
CN116240126A (en) | Multifunctional bacillus belgium SB10 and application thereof | |
CN115029261A (en) | Biocontrol compound microbial agent as well as preparation method and application thereof | |
CN114467975A (en) | Application of staphylococcus equi in prevention and treatment of fruit and vegetable diseases | |
CN109207398B (en) | Pseudomonas stutzeri and application thereof | |
CN110607249B (en) | Streptomyces biocontrol strain and application thereof | |
CN113416679A (en) | Bacillus methylotrophicus, microbial inoculum comprising bacillus methylotrophicus and application of bacillus methylotrophicus | |
CN117363537A (en) | Antagonistic strain Wt-1 of pseudomonas syringae kiwi fruit pathogenic variety and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |